Fungal Disease Awareness Week

Summary#

This resolution supports naming the third week of September "Fungal Disease Awareness Week." It notes that the Centers for Disease Control and Prevention (CDC) already observes a fungal awareness week each September and that the CDC message to "think fungus" can help save lives. The text says fungal infections are a growing public health concern, can resist antifungal drugs, and are often mistaken for bacterial or viral pneumonia. The resolution lists specific fungal illnesses (including Valley Fever, histoplasmosis, blastomycosis, aspergillosis, mucormycosis, fungal meningitis, severe ringworm, candidiasis, and Candida auris) and cites examples and counts from recent years: about 20,000 Valley Fever cases reported annually with 21,037 in 2023; a 2023 blastomycosis outbreak with 162 cases at a paper mill in Michigan; a 2025–2026 histoplasmosis outbreak in Tennessee; and 6,304 new clinical cases of Candida auris reported in 2024. The resolution urges better awareness, diagnosis, treatment, surveillance, outbreak response, laboratory capacity, infection control, occupational and environmental risk communication, research on diagnostics and treatments, and patient-centered care. It also honors patients, caregivers, clinicians, laboratorians, public health workers, researchers, and advocates.

What it means for you#

  • For the general public: The third week of September would be promoted for education and outreach about fungal infections and how to recognize them.
  • For people in areas with certain fungi (for example parts of the Southwest or Pacific): The resolution highlights Valley Fever and encourages better local awareness and diagnosis.
  • For healthcare professionals and laboratories: The resolution encourages clinicians to "think fungus" for pneumonia-like or unexplained illnesses, and it supports stronger lab testing, infection control, and surveillance for threats like Candida auris.
  • For employers and occupational settings: The text calls for greater awareness of environmental and workplace risks and better outbreak response capacity.

Expenses#

No publicly available information.

Proponents' View#

Supporters say raising awareness, improving testing and identification, expanding surveillance, and strengthening outbreak response will lead to earlier recognition, timelier and more appropriate treatment, better infection control, and ultimately save lives. They also emphasize honoring patients and health professionals and the need for research on diagnostics, antifungal drugs, and prevention.

Opponents' View#

No publicly available information.